JP2017160268A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017160268A5 JP2017160268A5 JP2017123029A JP2017123029A JP2017160268A5 JP 2017160268 A5 JP2017160268 A5 JP 2017160268A5 JP 2017123029 A JP2017123029 A JP 2017123029A JP 2017123029 A JP2017123029 A JP 2017123029A JP 2017160268 A5 JP2017160268 A5 JP 2017160268A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical
- composition
- antiarrhythmic
- administration
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 21
- 239000003416 antiarrhythmic agent Substances 0.000 claims 17
- 206010003658 Atrial Fibrillation Diseases 0.000 claims 5
- 210000003748 coronary sinus Anatomy 0.000 claims 5
- 239000000443 aerosol Substances 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 206010003130 Arrhythmia supraventricular Diseases 0.000 claims 2
- 206010003662 Atrial flutter Diseases 0.000 claims 2
- 208000003734 Supraventricular Tachycardia Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 230000033764 rhythmic process Effects 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 230000007704 transition Effects 0.000 claims 2
- DJBNUMBKLMJRSA-UHFFFAOYSA-N Flecainide Chemical compound FC(F)(F)COC1=CC=C(OCC(F)(F)F)C(C(=O)NCC2NCCCC2)=C1 DJBNUMBKLMJRSA-UHFFFAOYSA-N 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000001871 Tachycardia Diseases 0.000 claims 1
- 230000003288 anthiarrhythmic effect Effects 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 230000006793 arrhythmia Effects 0.000 claims 1
- 230000002763 arrhythmic effect Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 238000002565 electrocardiography Methods 0.000 claims 1
- 229960000449 flecainide Drugs 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000002085 persistent effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 210000003492 pulmonary vein Anatomy 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000006794 tachycardia Effects 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
- 206010047302 ventricular tachycardia Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21038209P | 2009-03-18 | 2009-03-18 | |
| US61/210,382 | 2009-03-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015149197A Division JP2015193657A (ja) | 2009-03-18 | 2015-07-29 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018204914A Division JP6715305B2 (ja) | 2009-03-18 | 2018-10-31 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017160268A JP2017160268A (ja) | 2017-09-14 |
| JP2017160268A5 true JP2017160268A5 (OSRAM) | 2017-10-26 |
Family
ID=42739985
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012500945A Withdrawn JP2012520890A (ja) | 2009-03-18 | 2010-03-18 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
| JP2015149197A Withdrawn JP2015193657A (ja) | 2009-03-18 | 2015-07-29 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
| JP2017123029A Pending JP2017160268A (ja) | 2009-03-18 | 2017-06-23 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
| JP2018204914A Active JP6715305B2 (ja) | 2009-03-18 | 2018-10-31 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
| JP2019162836A Active JP7071949B2 (ja) | 2009-03-18 | 2019-09-06 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012500945A Withdrawn JP2012520890A (ja) | 2009-03-18 | 2010-03-18 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
| JP2015149197A Withdrawn JP2015193657A (ja) | 2009-03-18 | 2015-07-29 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018204914A Active JP6715305B2 (ja) | 2009-03-18 | 2018-10-31 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
| JP2019162836A Active JP7071949B2 (ja) | 2009-03-18 | 2019-09-06 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US8974828B2 (OSRAM) |
| EP (3) | EP3552603B1 (OSRAM) |
| JP (5) | JP2012520890A (OSRAM) |
| AU (1) | AU2010226613B2 (OSRAM) |
| CA (2) | CA2835771C (OSRAM) |
| DK (1) | DK2413902T3 (OSRAM) |
| ES (3) | ES3036464T3 (OSRAM) |
| PL (1) | PL2413902T3 (OSRAM) |
| WO (1) | WO2010107964A1 (OSRAM) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2835771C (en) | 2009-03-18 | 2017-01-24 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| EP3834869B1 (en) | 2010-12-22 | 2024-06-05 | Syqe Medical Ltd. | System for drug delivery |
| US9713687B2 (en) | 2012-08-21 | 2017-07-25 | Philip Morris Usa Inc. | Ventilator aerosol delivery system with transition adapter for introducing carrier gas |
| US11191755B2 (en) | 2014-01-17 | 2021-12-07 | Cornell University | Compositions and methods for providing cardioprotective effects |
| TWI590837B (zh) * | 2014-03-25 | 2017-07-11 | 林信湧 | 一種用於治療心臟病之吸入式醫藥組成物及其備製方法 |
| US11298477B2 (en) | 2014-06-30 | 2022-04-12 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
| ES2786318T3 (es) | 2014-06-30 | 2020-10-09 | Syqe Medical Ltd | Dispositivo inhalador regulador de flujo |
| ES2898173T3 (es) * | 2014-06-30 | 2022-03-04 | Syqe Medical Ltd | Dispositivos y sistemas para la administración pulmonar de principios activos |
| WO2016118625A1 (en) * | 2015-01-20 | 2016-07-28 | Incarda Therapeutics, Inc. | Unit aerosol doses for anticoagulation |
| MA52480A (fr) * | 2015-04-14 | 2022-03-09 | Milestone Pharmaceuticals Inc | Sels hautement solubles dans l'eau d'un agent bloquant les canaux calciques à base de phénylalkylamine à brève durée d'action et leurs utilisations |
| EP3851102B1 (en) | 2016-01-06 | 2025-04-16 | Syqe Medical Ltd. | Low dose therapeutic treatment |
| CN109069495A (zh) | 2016-02-01 | 2018-12-21 | 英凯达治疗公司 | 电子监测联合吸入药理学疗法管理包括心房颤动在内的心律失常 |
| CN110869018A (zh) * | 2017-05-10 | 2020-03-06 | 英凯达治疗公司 | 通过肺部施用治疗心脏病况的单位剂量、气雾剂、试剂盒和方法 |
| WO2019183470A2 (en) * | 2018-03-22 | 2019-09-26 | Incarda Therapeutics, Inc. | A novel method to slow ventricular rate |
| JP2021526900A (ja) * | 2018-06-05 | 2021-10-11 | インカーダ セラピューティクス， インコーポレイテッド | エアロゾルを用いるブルガダ症候群の診断方法 |
| EP3806839B1 (en) * | 2018-06-14 | 2024-08-07 | Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") | Retinoic acid receptor-beta2 agonist with cardioprotective effects |
| US12396970B2 (en) | 2021-08-20 | 2025-08-26 | AltaThera Pharmaceuticals LLC | Anti-arrhythmic compositions and methods |
| US11696902B2 (en) | 2018-08-14 | 2023-07-11 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US11344518B2 (en) | 2018-08-14 | 2022-05-31 | AltaThera Pharmaceuticals LLC | Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame |
| US11610660B1 (en) | 2021-08-20 | 2023-03-21 | AltaThera Pharmaceuticals LLC | Antiarrhythmic drug dosing methods, medical devices, and systems |
| US10512620B1 (en) | 2018-08-14 | 2019-12-24 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US11007185B2 (en) | 2019-08-01 | 2021-05-18 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
| JP7190077B2 (ja) * | 2019-08-01 | 2022-12-14 | インカーダ セラピューティクス， インコーポレイテッド | 抗不整脈製剤 |
| CA3200432A1 (en) | 2020-12-17 | 2022-06-23 | Incarda Therapeutics, Inc. | Kits and methods for induction of cardioversion in subjects with atrial arrhythmias |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| IT1016489B (it) | 1974-03-18 | 1977-05-30 | Isf Spa | Inalatore |
| SE408265B (sv) | 1975-12-12 | 1979-06-05 | Draco Ab | Anordning for koldioxiddriven endosaerosol, avsedd for inhalering |
| US4247066A (en) | 1978-02-21 | 1981-01-27 | General Dynamics Corporation | Airfoil variable cambering device and method |
| IT1116047B (it) | 1979-04-27 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma |
| DE3634952A1 (de) | 1986-10-14 | 1988-04-21 | Bayer Ag | Imidazo-pyrrolo-pyridin-derivate |
| JP3202705B2 (ja) * | 1987-11-06 | 2001-08-27 | リサーチ ディベロップメント ファンデーション | 医療用のリポソームおよび薬物含有リポソームのエアゾールの小粒子 |
| US4962095A (en) * | 1989-02-15 | 1990-10-09 | E. R. Squibb & Sons, Inc. | Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| ES2141108T3 (es) | 1991-07-02 | 2000-03-16 | Inhale Inc | Metodo y dispositivo para proporcionar medicamentos en aerosol. |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| JPH10501519A (ja) | 1994-03-07 | 1998-02-10 | インヘイル・セラピューティック・システムズ | インシュリンを肺に送給できる方法および組成物 |
| US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| CA2190502A1 (en) | 1994-05-18 | 1995-11-23 | Robert M. Platz | Methods and compositions for the dry powder formulation of interferons |
| JP3388896B2 (ja) | 1994-08-08 | 2003-03-24 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
| US5693609A (en) | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
| EP0820277B1 (en) | 1995-04-14 | 2005-01-26 | Nektar Therapeutics | Powdered pharmaceutical formulations having improved dispersibility |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US6503480B1 (en) | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US6001336A (en) | 1996-12-31 | 1999-12-14 | Inhale Therapeutic Systems | Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof |
| WO1999016421A1 (en) | 1997-09-29 | 1999-04-08 | Inhale Therapeutic Systems, Inc. | Stabilized bioactive preparations and methods of use |
| US20020017295A1 (en) | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
| WO1999016420A1 (en) | 1997-09-29 | 1999-04-08 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in nebulizers |
| US6541479B1 (en) * | 1997-12-02 | 2003-04-01 | Massachusetts College Of Pharmacy | Calcium channel blockers |
| US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
| DE19835346A1 (de) | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
| CZ20011581A3 (cs) | 1998-11-12 | 2001-12-12 | Frank G. Pilkiewicz | Systém pro podávání bioaktivní sloučeniny inhalací |
| ATE331544T1 (de) | 1999-05-28 | 2006-07-15 | Nektar Therapeutics | Gerät und verfahren zur aerosolisierung einer pharmazeutischen pulverzusammensetzung |
| AU782841B2 (en) * | 2000-04-17 | 2005-09-01 | Vectura Limited | Improvements in or relating to formulations for use in inhaler devices |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| DK1280520T4 (en) | 2000-05-10 | 2018-06-25 | Novartis Ag | Phospholipid based powders for drug delivery |
| US6357490B1 (en) | 2000-08-22 | 2002-03-19 | Advanced Inhalation Research, Inc. | System, method and apparatus for filling containers |
| FI20002215A0 (fi) * | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
| AU2002245181B2 (en) | 2000-12-21 | 2006-06-29 | Nektar Therapeutics | Pulmonary delivery of polyene antifungal agents |
| WO2002080859A2 (en) | 2001-03-20 | 2002-10-17 | Glaxo Group Limited | Inhalation drug combinations |
| US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
| US20080038363A1 (en) * | 2001-05-24 | 2008-02-14 | Zaffaroni Alejandro C | Aerosol delivery system and uses thereof |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US6737042B2 (en) * | 2001-05-24 | 2004-05-18 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| US7090830B2 (en) * | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| AU2002340083A1 (en) * | 2001-09-28 | 2003-04-07 | Kurve Technology, Inc | Nasal nebulizer |
| RU2332220C2 (ru) * | 2002-04-18 | 2008-08-27 | Си Ви Терапьютикс, Инк. | Способ снижения частоты сердечных сокращений, включающий введение агониста рецептора аденозина а1 вместе с бета-блокатором, блокатором кальциевых каналов или сердечным гликозидом |
| US8245708B2 (en) | 2002-05-07 | 2012-08-21 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
| US7607436B2 (en) | 2002-05-06 | 2009-10-27 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
| CA2485340C (en) | 2002-05-07 | 2015-09-29 | The State University Of New York At Stony Brook | Methods, devices and formulations for targeted endobronchial therapy |
| JP2006513236A (ja) | 2002-12-31 | 2006-04-20 | ネクター セラピューティクス | 不溶性活性物質を伴う医薬製剤 |
| AU2004238217A1 (en) * | 2003-04-24 | 2004-11-25 | Aderis Pharmaceuticals, Inc. | Method of treating atrial fibrillation or atrial flutter |
| WO2005018635A2 (en) * | 2003-08-07 | 2005-03-03 | Cardiome Pharma Corp. | Ion channel modulating activity i |
| US20060034906A1 (en) * | 2004-05-21 | 2006-02-16 | Transave, Inc. | Treatment of lung diseases and pre-lung disease conditions |
| US8569277B2 (en) * | 2004-08-11 | 2013-10-29 | Palo Alto Investors | Methods of treating a subject for a condition |
| US20070086957A1 (en) * | 2005-10-10 | 2007-04-19 | Thierry Bouyssou | Combination of medicaments for the treatment of respiratory diseases |
| BRPI0617655A2 (pt) * | 2005-10-21 | 2016-08-23 | Merck & Co Inc | composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica |
| ITMI20051999A1 (it) * | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
| CL2007002689A1 (es) | 2006-09-18 | 2008-04-18 | Vitae Pharmaceuticals Inc | Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras. |
| NZ576637A (en) | 2006-10-25 | 2012-05-25 | Novartis Ag | Powder dispersion apparatus with and mediciment receptacles that are cut open using an elliptical arc shaped knife blade oriented to yaw between 4 and 12 degrees |
| WO2008066745A1 (en) * | 2006-11-22 | 2008-06-05 | Reliant Pharmaceuticals, Inc. | Prophlyaxis and treatment of atrial fibrillation with omega-3 fatty acids |
| TW200840578A (en) | 2006-12-15 | 2008-10-16 | Procter & Gamble | Compositions of azimilide dihydrochloride |
| WO2008134630A1 (en) * | 2007-04-30 | 2008-11-06 | Apt Pharmaceuticals | Dexrazoxane compounds for cardioprotection |
| US20080275036A1 (en) * | 2007-05-02 | 2008-11-06 | Apt Pharmaceuticals, Inc. | Prevention and treatment of cardiac conditions |
| CA2733930A1 (en) | 2008-08-14 | 2010-02-18 | The Uab Research Foundation | Anti-arrhythmia agents, methods of their use, methods of their identification, and kits therefore |
| CA2734780C (en) | 2008-08-22 | 2016-07-05 | Milestone Pharmaceuticals Inc. | Short acting benzothiazepine calcium channel blockers and uses thereof |
| MX356209B (es) * | 2008-09-23 | 2018-05-18 | Laboratory Skin Care Inc | Partículas de fosfato de calcio nanoporosas, esféricas, rígidas, uniformes cargadas de agente activo y métodos para su fabricación y su uso. |
| CA2835771C (en) | 2009-03-18 | 2017-01-24 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
-
2010
- 2010-03-18 CA CA2835771A patent/CA2835771C/en active Active
- 2010-03-18 PL PL10754091T patent/PL2413902T3/pl unknown
- 2010-03-18 ES ES19176272T patent/ES3036464T3/es active Active
- 2010-03-18 JP JP2012500945A patent/JP2012520890A/ja not_active Withdrawn
- 2010-03-18 WO PCT/US2010/027740 patent/WO2010107964A1/en not_active Ceased
- 2010-03-18 EP EP19176305.1A patent/EP3552603B1/en active Active
- 2010-03-18 EP EP19176272.3A patent/EP3552602B1/en active Active
- 2010-03-18 ES ES19176305T patent/ES3003038T3/es active Active
- 2010-03-18 DK DK10754091.6T patent/DK2413902T3/da active
- 2010-03-18 EP EP10754091.6A patent/EP2413902B1/en active Active
- 2010-03-18 AU AU2010226613A patent/AU2010226613B2/en active Active
- 2010-03-18 US US13/257,249 patent/US8974828B2/en active Active
- 2010-03-18 CA CA2755809A patent/CA2755809C/en active Active
- 2010-03-18 ES ES10754091T patent/ES2750359T3/es active Active
-
2015
- 2015-02-26 US US14/632,252 patent/US10045939B2/en active Active
- 2015-07-29 JP JP2015149197A patent/JP2015193657A/ja not_active Withdrawn
-
2017
- 2017-06-23 JP JP2017123029A patent/JP2017160268A/ja active Pending
-
2018
- 2018-06-20 US US16/013,165 patent/US20180296480A1/en not_active Abandoned
- 2018-06-20 US US16/013,178 patent/US20180318213A1/en not_active Abandoned
- 2018-10-26 US US16/172,456 patent/US20190060230A1/en not_active Abandoned
- 2018-10-31 JP JP2018204914A patent/JP6715305B2/ja active Active
-
2019
- 2019-09-06 JP JP2019162836A patent/JP7071949B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017160268A5 (OSRAM) | ||
| JP2015193657A5 (OSRAM) | ||
| JP2019203032A5 (OSRAM) | ||
| JP2020519628A5 (OSRAM) | ||
| Piotrowski et al. | Antazoline for rapid termination of atrial fibrillation during ablation of accessory pathways | |
| Marum et al. | Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration | |
| Huang et al. | Sympathetic denervation of heart and kidney induces similar effects on ventricular electrophysiological properties | |
| CN101850098B (zh) | 一种具有养血益气、复脉定悸的中药组合物及其新用途 | |
| WO2024193467A1 (zh) | 柏科植物提取物及其在制备心律失常的预防和治疗药物中的应用 | |
| Paraskevaidis et al. | Narrow QRS complex in idiopathic (fascicular) left ventricular tachycardia | |
| CN104873527B (zh) | 一种用于治疗心血管疾病的天然药物组合物 | |
| Oral et al. | Comparison of amiodarone versus ibutilide for the prevention of immediate recurrences of atrial fibrillation during pulmonary vein isolation | |
| Kukar et al. | Idiopathic fascicular left ventricular tachycardia: case report and review of the literature | |
| Silva et al. | Radiofrequency ablation in the treatment of focal atrial fibrillation using circumferential mapping and segmentary disconnection of pulmonary veins | |
| LACOMBE et al. | Intravenous flecainide in the management of acute supraventricular tachyarrhythmias | |
| Voskoboinik et al. | Ventricular fibrillation storm in a young man with early repolarisation abnormality: the role of isoprenaline and quinidine. | |
| CN105963292B (zh) | 一种用于心肌梗死治疗的药物组合物及其应用 | |
| Belardinelli et al. | Hand-held Breath-Actuated Nebulizer for Delivery of Flecainide to the Heart: Dose-Concentration Dependent Pharmacokinetics and QRS Interval Prolongation of Inhaled Flecainide in Healthy Volunteers | |
| Rathod et al. | PREPARATIONS AND EVALUATION ASHWAGANDHA CAPSULE FOR ANTIARRHYTHMIC PROPERTIES | |
| Kiuchi et al. | The Effectiveness of Continuous Intravenous Administration of Landiolol for Supraventricular Tachycardia | |
| Santinelli et al. | Paroxysmal supraventricular tachycardia: experience with propafenone | |
| Carmo et al. | P1813 Best voltage threshold to localize ablation targets in patients with ventricular tachycardia using rhythmia mapping system | |
| de Antonio et al. | Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration☆ | |
| Yuzawa et al. | High Incidence of Inappropriate ICD Therapies in Young Patients with Catecholaminergic Polymorphic Ventricular Tachycardia | |
| CN100444851C (zh) | 菊花总黄酮在制备治疗心律失常药物中的应用 |